| V |
|
Veillonella parvula LPS stimulates cytokine production in a TLR4-dependent manner
|
| Capicotto R., Vinci M., Lamberti A.G., Quirino A., Matera G., Liberto M.C., Netea M.G., Joosten L.A.B., van der Meer J.W.M., Focà A. |
| |
|
Vibrio cholerae among stool samples of patients with diarrhoea and PCR detection of two housekeeping genes hly and recA
|
| Dashtbani A., Bakhshi B., Oskoui M., Pourshafie M.R. |
| |
|
Vibrio cholerae O139 requires neither capsule nor lipopolysaccharide O side chain to grow inside Acanthamoeba castellanii
|
| Abd H., Saeed A., Edvinsson B., Weintraub A., Sandström G. |
| |
|
Vaccinal strategy against Clostridium difficile associated disease with surface proteins of C. difficile
|
| Péchiné S., Denève-Larrazet C., Hoys S., Alkhuder K., Janoir C., Collignon A. |
| |
|
Validation of agar dilution for susceptibility testing of coagulase-negative staphylococci to tigecycline
|
| John M., Daniel J., Diagre D., Wilson B., Milburn S., Hussain Z. |
| |
|
Validation of inoculation of the VITEK 2 AST cards from SA-select agar for S. aureus
|
| Laffut W., Besbrugge J., Frans J. |
| |
|
Validation of M.I.C. Evaluator strips following ISO guidelines
|
| Nabuurs-Franssen M.H., Bohne M.T.H., Mouton J.W. |
| |
|
Validation of the Abbott Architect syphilis TP test against the Dade Behring Enzygnost syphilis ELISA and the Fujirebio Treponema pallidum particle agglutination test
|
| Benne C.A., Luchtenburg A., Drenth J., Feikens H., Meijer B.C. |
| |
|
Validation of the extended-spectrum b-lactamase phenotype with molecular methods
|
| Bruderer T., Poirel L., Adler H., Nordmann P., Frei R. |
| |
|
Value of antibodies to the C. albicans enolase for the diagnosis of invasive candidiasis in non-neutropenic critically ill patients
|
| Castro C., Martin-Mazuelos E., Ruiz-Santana S., Carolina A., Carrasco N., Perez L., Marin M., Ubeda A. |
| |
|
Value of Gram stain and quantitative culture of washed sputum samples in patients with lower respiratory tract infections
|
| Ziyade N., Yagci A. |
| |
|
Value of pharmacokinetic/pharmacodynamic in dose management of ceftazidime and imipeneme in ICUs
|
| Coudrot M., Carricajo A., Guyomarc'h S., Morel J., Auboyer C., Zeni F., Aubert G. |
| |
|
vanB2-Tn5382 typing in enterococcal clones disseminated around 16 hospitals in Chile
|
| López M., Saavedra G., Rodriguez-Baños M., Hormazábal J.C., Maldonado A., Silva J., Torres C., del Campo R. |
| |
|
Vancomycin is not obsolete
|
| Eliopoulos G. |
| |
|
Vancomycin MIC distributions in MRSA isolates from a large acute English hospital: no evidence of MIC shift, 1999–2006
|
| Bowker K., Tomaselli S., MacGowan A. |
| |
|
Vancomycin-resistant enterococci: validation of susceptibility testing and in vitro activity of novel antibiotics
|
| Rathe M., Kristensen L., Schumacher H. |
| |
|
Variability in cefazolin concentrations in amniotic fluid: the relevance of gestational age
|
| Allegaert K., van Mieghem T., Verbesselt R., de Hoon J., Naulaers G., Deprest J., Devlieger R. |
| |
|
Variability of Inc group of conjugative plasmids and CTX-M gene environments in Enterobacteriaceae nosocomial strains isolated from Russia
|
| Fursova N.K., Abaev I.V., Pryamchuk S.D., Shishkova N.A., Pecherskikh E.I., Korobova O.V., Kruglov A.N., Weigel L.M., Rasheed J.K. |
| |
|
Variable number tandem repeat assay for typing meticillin-resistant Staphylococcus aureus
|
| Rivero-Pérez B., Pérez-Roth E., Alcoba-Flórez J., Laich F., Espinoza-Jiménez A., Méndez-Álvarez S. |
| |
|
Varicella vaccination in HIV-positive individuals, a time to act
|
| de Barra E., Jackson A., Mallon J., Clarke S., Lyons F., Dowling C., Moriarty M., Bergin C. |
| |
|
Varicella zoster virus latency: implications for new vaccines
|
| Cohen J. |
| |
|
Ventilator-associated pneumonia and attributable mortality: a systematic review of observational studies
|
| Melsen W.G., Rovers M.M., Bonten M.J.M. |
| |
|
Ventilator-associated pneumonia in a tertiary hospital's polyvalent intensive care unit: a sixteen-month study
|
| Kydona C., Pappas P., Avgousti D., Giasnetsova T., Tsiotras C., Gritsi-Gerogianni N. |
| |
|
Viability of live-attenuated vaccine strains in a pharmaceutical dump
|
| Bianchi S., Canuti M., Zappa A., Koncan R., Cornaglia G., Tanzi E., Tridente G., Amendola A. |
| |
|
VIDAS C. difficile toxin A&B assay performance evaluation and epidemiological analysis of samples collected in UK and US
|
| Foussadier A., Rolland D., Bridon L., Rice B., Brazier J., Hall V., Young S., Smith R., Dumas N., Amphlett M., Nancekievill K., Delaney C., Apcar S. |
| |
|
VIM-1 and CTX-M-9 in E. cloacae, K. pneumoniae and K. oxytoca clinical strains
|
| Miró E., Segura C., Navarro F., Horcajada J., Sorli L., Alvarez F., Salvadó M. |
| |
|
Viral aetiology of hospitalised patients with community-acquired pneumonia in Hong Kong
|
| Ip M., Lee N., Rainer T., Antonio G., Lui G., Chau S., Ng F., Leung E., Hui D., Chan P. |
| |
|
Virological and immunological monitoring of human cytomegalovirus infection in heart and small bowel/multivisceral transplantation
|
| Lazzarotto T., Chiereghin A., Gabrielli L., Pinna A.D., Lauro A., Dazzi A., Zanfi C., Cescon M., Potena L., Magelli C., Petrisli E., Monari P., Pop S., Landini M.P. |
| |
|
Virulence factors and antimicrobial resistance in H. pylori clinical isolates by a multiple correspondence analysis
|
| Garcia-Campos J.A., Alarcon T., Domingo D., Lopez-Brea M. |
| |
|
Virulence genotypes of Escherichia coli strains of human and avian origin in relation to ciprofloxacin resistance status
|
| Cerquetti M., Graziani C., Parisi G., Tomei F., Fioravanti A., Corrò M., Morabito S., Luzzi I., Caprioli A. |
| |
|
Virulence potential of extraintestinal pathogenic Escherichia coli strains isolated from skin, wound and soft tissue infections
|
| Starcic Erjavec M., Petkovsek Z., Elersic K., Gubina M., Zgur-Bertok D. |
| |
|
Virulence traits of Escherichia coli clinical isolates neonatal sepsis. Comparison between strains causing early and late neonatal sepsis
|
| Soto S., Bosch J., Jimenez de Anta M.T., Vila J. |
| |
|
Virus-specific antibody activity of different subclasses of immunoglobulins G in Cytomegalovirus infections
|
| Matveeva E., Burkov A., Obriadina A. |
| |
|
VZIG administration in pregnant women exposed to chickenpox
|
| Troughton J., Crealey G., Crawford V., McCaughey C., Wyatt D., O'Neill H., Coyle P. |
| |
